NCT02192931View on ClinicalTrials.gov

A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
DepressionDual DiagnosisDrug Addiction
Interventions
DRUG

Creatine monohydrate

Trial Locations (1)

84108

University of Utah, Salt Lake City

All Listed Sponsors
lead

Perry Renshaw

OTHER

NCT02192931 - A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users | Biotech Hunter | Biotech Hunter